Qiagen N.V. financial data

Symbol
QGEN on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
Hulsterweg 82, Pl Venlo, Netherlands
State of incorporation
Netherlands
Fiscal year end
December 31
Former names
QIAGEN NV (to 2/14/2020)

Key Ratios

Label TTM Value / Value Unit Change %
Operating Margin 24.8 % -11.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 228M shares +0.28%
Common Stock, Value, Issued 2.7M USD 0%
Weighted Average Number of Shares Outstanding, Basic 228M shares -0.18%
Weighted Average Number of Shares Outstanding, Diluted 230M shares -0.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.14B USD -4.89%
Selling and Marketing Expense 474M USD +3.91%
General and Administrative Expense 130M USD +1.29%
Operating Income (Loss) 531M USD -15.7%
Nonoperating Income (Expense) -18.9M USD -344%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 513M USD -18.1%
Income Tax Expense (Benefit) 89.4M USD -21.1%
Net Income (Loss) Attributable to Parent 423M USD -17.4%
Earnings Per Share, Basic 1.86 USD/shares -17.3%
Earnings Per Share, Diluted 1.84 USD/shares -16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 731M USD -17%
Accounts Receivable, after Allowance for Credit Loss, Current 324M USD -10.6%
Inventory, Net 358M USD +9.29%
Assets, Current 2.39B USD +13.5%
Property, Plant and Equipment, Net 662M USD +3.76%
Operating Lease, Right-of-Use Asset 95.5M USD -5.32%
Intangible Assets, Net (Excluding Goodwill) 545M USD -13.2%
Goodwill 2.35B USD +0.08%
Other Assets, Noncurrent 203M USD -12%
Assets 6.29B USD +2.29%
Accounts Payable, Current 98.7M USD -2.46%
Employee-related Liabilities, Current 99.9M USD -0.86%
Accrued Liabilities, Current 62.5M USD +15.1%
Contract with Customer, Liability, Current 69M USD +8.89%
Liabilities, Current 975M USD -35.8%
Operating Lease, Liability, Noncurrent 71.4M USD -6.7%
Other Liabilities, Noncurrent 218M USD -11.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -404M USD -23.7%
Retained Earnings (Accumulated Deficit) 2.16B USD +20.6%
Stockholders' Equity Attributable to Parent 3.47B USD +12%
Liabilities and Equity 6.29B USD +2.29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 715M USD +11.9%
Net Cash Provided by (Used in) Financing Activities -126M USD +16.3%
Net Cash Provided by (Used in) Investing Activities -727M USD -259%
Common Stock, Shares Authorized 410M shares 0%
Common Stock, Shares, Issued 231M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -150M USD -153%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 731M USD -17%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23.2M USD +7.5%
Deferred Tax Assets, Valuation Allowance 21.3M USD -0.29%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.26 pure +4%
Deferred Tax Assets, Gross 155M USD -2.41%
Operating Lease, Liability 93.6M USD -5.03%
Depreciation 89.5M USD +4.8%
Payments to Acquire Property, Plant, and Equipment 129M USD -32%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 346M USD -19.5%
Lessee, Operating Lease, Liability, to be Paid 101M USD -4.2%
Property, Plant and Equipment, Gross 1.17B USD -8.3%
Operating Lease, Liability, Current 22.2M USD +0.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.7M USD -3.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 23.7M USD +0.45%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Deferred Income Tax Expense (Benefit) -9.6M USD -81.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.31M USD +7.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.6M USD -2.38%
Deferred Tax Assets, Operating Loss Carryforwards 53.2M USD -21.7%
Deferred Federal Income Tax Expense (Benefit) -683K USD +61.5%
Current Income Tax Expense (Benefit) 99M USD -16.5%
Unrecognized Tax Benefits 79.3M USD -23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.36M USD +0.98%
Operating Lease, Payments 26.8M USD -2.14%
Additional Paid in Capital 1.87B USD +2.72%
Current Federal Tax Expense (Benefit) 9.67M USD +464%
Amortization of Intangible Assets 93.7M USD -10.2%
Depreciation, Depletion and Amortization 208M USD -3.04%
Deferred Tax Assets, Net of Valuation Allowance 133M USD -2.74%
Share-based Payment Arrangement, Expense 49.5M USD +29%
Interest Expense 58.4M USD +7.12%